Silence Therapeutics PLC SLNCF:OTCPK

RT Quote | Exchange | USD
Last | 12/01/21 EST
7.47UNCH (UNCH)
52 week range
5.79 - 9.25
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close7.47
  • 52 Week High9.25
  • 52 Week High Date06/04/21
  • 52 Week Low5.79
  • 52 Week Low Date12/03/20

Key Stats

  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume1,199.2
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change7.14

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close7.47
  • 52 Week High9.25
  • 52 Week High Date06/04/21
  • 52 Week Low5.79
  • 52 Week Low Date12/03/20
  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume1,199.2
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change7.14

RATIOS/PROFITABILITY

  • EPS (TTM)-0.67
  • P/E (TTM)-11.09
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Silence Therapeutics PLC

There is no recent news for this security.

Profile

MORE
Silence Therapeutics plc is a biotechnology company. The Company is focused on discovering and developing molecules combining short interfering ribonucleic acid (siRNA), to inhibit the expression of target genes in the pathology of diseases with unmet medical need. Its siRNA molecules are designed to harness the body’s natural mechanism of RNA interference (RNAi), by specifically binding to and degrading messenger RNA, or mRNA, molecules that encode specific targeted...
Iain Ross
Non-Executive Chairman
Mark Rothera
President
Craig Tooman
Chief Financial Officer
Address
72 Hammersmith Road
London
W14 8TH
United Kingdom